DPHARMA News

Duopharma's Attributable Income Shrinks in Q1; Shares Down 2%

DuoPharma (KLSE:DPHARMA) booked an attributable income to shareholders of 11.9 million ringgit in Q1, compared with 13.6 million ringgit in the year ago period, according to a filing with the Malaysia

MT NewswiresMay 24 16:57

Duopharma Biotech Berhad (KLSE:DPHARMA) Investors Are Sitting on a Loss of 42% If They Invested Three Years Ago

Yahoo FinanceMay 24 08:54

Duopharma's 1Q Net Profit Down 33% on Higher Costs, Unfavorable Exchange Rates

Duopharma Biotech Bhd’s (KL:DPHARMA) net profit dropped 32.5% for the first quarter amid lower demand in the prescription pharmaceutical products, higher costs as well as unfavorable exchange rates.

The Edge MarketsMay 23 19:48

Duopharma Biotech Clinches MYR578 Million Supply Deals

Duopharma Biotech (KLSE:DPHARMA), through two wholly-owned subsidiaries, accepted 11 letters of offers from Pharmaniaga Logistics worth an aggregate 578 million ringgit for the supply of pharmaceutica

MT NewswiresMay 1 14:43

While Individual Investors Own 28% of Duopharma Biotech Berhad (KLSE:DPHARMA), Sovereign Wealth Funds Are Its Largest Shareholders With 51% Ownership

Yahoo FinanceApr 24 09:10

Are Duopharma Biotech Berhad's (KLSE:DPHARMA) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Yahoo FinanceMar 24 10:12

Duopharma Biotech Berhad (KLSE:DPHARMA) Pays A RM00.018 Dividend In Just Three Days

Yahoo FinanceMar 3 08:45

Duopharma Biotech's Profit Plummets in Q4 2023

Duopharma Biotech (KLSE:DPHARMA) posted a profit attributable to owners of 8.5 million ringgit in the fourth quarter of 2023, plunging from 17.2 million ringgit a year earlier. Earnings per share drop

MT NewswiresFeb 23 16:16

Calculating The Fair Value Of Duopharma Biotech Berhad (KLSE:DPHARMA)

Yahoo FinanceJan 1 09:15

Duopharma Biotech Issues Further Islamic Debt Worth MYR29 Million

Duopharma Biotech (KLSE:DPHARMA) issued further Islamic debt or Sukuk Wakalah worth 29 million ringgit under the Sukuk Wakalah Program. The debt securities have tenures of seven and 10 years, accordin

MT NewswiresDec 18, 2023 14:32

Duopharma Biotech Berhad's (KLSE:DPHARMA) Investors Will Be Pleased With Their Decent 80% Return Over the Last Five Years

Yahoo FinanceDec 7, 2023 06:21

Duopharma Biotech's Profit Drops in Q3

Duopharma Biotech (KLSE:DPHARMA) posted a profit attributable to owners of 9 million ringgit in the third, plunging from 16.3 million ringgit a year earlier. Earnings per share dropped to 0.0093 ringg

MT NewswiresNov 9, 2023 12:59

Duopharma Biotech Malaysia 3rd-Quarter 2023 Earnings Summary Table

Duopharma Biotech (7148.KU) - Malaysia (3rd) quarter ended Sep 30: Figures Are In Ringgit (MYR). 2023 2022 Revenue

Dow JonesNov 8, 2023 17:50

Duopharma Biotech Bags Supply Deal Extension From Pharmaniga

Duopharma Biotech's (KLSE:DPHARMA) said its unit Duopharma (M) secured an extension from Pharmaniaga Logistics. The deal pertains to the supply of pharmaceutical and non-pharmaceutical products to gov

MT NewswiresOct 25, 2023 15:45

Declining Stock and Decent Financials: Is The Market Wrong About Duopharma Biotech Berhad (KLSE:DPHARMA)?

Yahoo FinanceSep 26, 2023 14:50

Duopharma Biotech Berhad (KLSE:DPHARMA) Is Due To Pay A Dividend Of MYR0.005

Yahoo FinanceAug 27, 2023 08:03